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inferior wall infarction. 93 patients had clinical markers of partial
or complete ST resolution after thrombolysis. Arrhythmia
observed were VPC (90%), NSVT (61%), APC (62%), SVT (47%), A.
ﬁb (2%), 2:1 AV block and bifascicular block (2% each), and new
LBBB (6%). One or more major tachyarrhythmia were observed in
84% of patients while bradyarrhythmia were noted in 3% of
patients. Arrhythmia were more frequently observed in age
>60 yrs, diabetics, smokers, late presenters, extensive AWMI,
and patients with failed thrombolysis. In-hospital MAACE viz,
LVF, cardiogenic shock, post-MI angina, were signiﬁcantly higher
in patients having ventricular bigemini, ventricular tachycardia,
NSVT, 2:1 AV block, bifascicular block, LBBB, and SVT early after
STEMI. Likewise, 4 patients who died within 1month of STEMI had
high grade AV block, NSVT, A. Fibrillation at initial presentation.
Major cardiac arrhythmia early after STEMI insight into future
early MACE and may decide early coronary intervention in these
patients.
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Introduction: Coronary artery disease (CAD) is a major cause of
mortality and morbidity among elderly women in developing
countries. But there is lack of awareness about this in general
population as well as in health care professionals. Females are
underrepresented inmost of the CAD studies. Most of the research
based evidence has been gathered by studies on males. The pur-
pose of this study was to investigate demographic proﬁle, risk
factors, angiographic characteristics, and treatment recommenda-
tions in female patients with CAD.
Materials and methods: This prospective study included all 753
females admitted from January 2014 to January 2015 at Cardiology
Department in our institute. These patientswere selected based on
the clinical features, electrocardiogram (ECG) ﬁndings, stress test,
and biochemical markers. The study protocol included detailed
history, clinical examination, and investigations. Type of presen-
tation, i.e. ST elevation myocardial infarction (STEMI), non-ST
elevation myocardial infarction (NSTEMI), unstable angina
(USA), chronic stable angina (CSA) was recorded. Angiographic
data was collected from angiographic records. Data was analysed
using statistical methods.
Results:
1. Themean age of presentation of CAD in females was 58.6  10.4
years. The most common age group was 51–60 years (37.1%).
Only 2 patients with age less than 30 years were found to have
MI (Table 1).
2. 80.98% females were from postmenopausal age group and
remaining 19% were from premenopausal age group.
3. Multiparity was associated with increased risk of CAD (Table 2).
4. Most common risk factors were hypertension (44%), diabetes
(32.84%), family history of CAD (30%), dyslipidemia (29.78%),
obesity(28.32%), and tobacco use (10.37%) (Table 3).
5. Most common clinical presentation was unstable angina
(32.04%) followed by chronic stable angina (30.58%), STEMI
(26.32%), NSTEMI (7.84%), and atypical chest pain (3%).
6. 54 patients (7.18%) came with cardiogenic shock at the time of
presentation. 166 (22.07%) patients had arrhythmias with
tachyarrhythmia (91.53%)more common than bradyarrhythmia
(8.47%). Past history of ischemic heart disease was found in 88
(11.7%) patients amongst which 46 (52.27%) had undergone
coronary angioplasty in the past.
7. Other associated conditions were CKD (4.12%), hypothyroidism
(3.6%), and hyperthyroidism (2 patients). 87 patients (11.56%)
had been found to have depressed LV function.
8. The most common ﬁnding on coronary angiography (CAG) was
single vessel disease (39.22%) followed by double vessel disease
(20.34%), and triple vessel disease (7.84%) (Table 4).
9. Left main artery involvement was seen in 52 (6.9%) patients.
Renal artery involvement was found in 42 (5.58%) patients. 248
(33%) patients were found to have normal CAG. Calciﬁed
coronary lesions were seen in 116 (15.15%) patients while
thrombotic lesions were seen in 135 (17.95%) patients. Chronic
total occlusion was seen in 53 (7%) patients.
Conclusion: Our study showed that CAD is more common in
postmenopausal females and parity should be considered as
one of the important risk factors. Coronary microvascular dys-
function is present in approximately one-third of females with
chest pain in the absence of CAD. Therefore, microvascular
dysfunction should be considered in females with chest pain
Table 1 – Age distribution.
Age group No. of patients
21–30 2
31–40 85
41–50 196
51–60 279
61–70 149
71–80 34
>80 7
Table 2 – Distribution of parity among patients.
No. of children No. of patients
0 37
1 74
2 228
3 362
>3 151
Table 3 – Risk factor profile.
Risk factors Percentage of patients
Hypertension 44
DM 32.84
Family history 30
Dyslipidemia 29.78
Obesity 28.32
Tobacco use 10.37
Table 4 – Coronary profile of patients.
Vessel involvement No. of patients
Single 295
Double 153
Triple 59
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not due to CAD. Identiﬁcation and reduction of risk factors is
important in preventing morbidity and mortality due to CAD in
females.
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Objectives: This study sought to compare high intensity statin
versus low intensity statin therapy in Indian patients with ST-
segment elevation myocardial infarction (STEMI) undergoing
thrombolysis.
Background: Previous randomized trials have demonstrated that
statin pre-treatment reduced major adverse cardiac events
(MACEs) in patients with stable angina pectoris and acute coronary
syndrome. However, randomized studies of statin therapy in
Indian patients with STEMI are scarce.
Methods: Of 1230 patients with acute STEMI, 460 patients satisﬁed
the inclusion criteria and were randomized to 80-mg atorvastatin
(n = 225) or 10-mg atorvastatin (n = 235) arms for pre-treatment
before thrombolytic therapy. The primary end point was 30-day
incidence ofMACE including death and nonfatalMI. Secondary end
points included readmission and ST-segment resolution at 90 min
after thrombolysis.
Results: The two groups did not differ in their primary endpoints.
MACE occurred in 12 (5.33%) and 14 (5.96%) patients in the 80-mg
and 10-mg atorvastatin pre-treatment arms, respectively
( p = 0.92). But ST-segment resolution was signiﬁcantly higher in
the 80-mg atorvastatin arm (64.87  14.84 vs 54.84  16.01%,
p < 0.001). Of note, myalgia was signiﬁcantly more in 80 mg statin
group (18.22% vs 7.66%, p = 0.001).
Conclusions: High-dose atorvastatin pre-treatment before
thrombolysis did not show a signiﬁcant difference of MACEs
compared with low dose atorvastatin but did show signiﬁcant
improvement in immediate coronary ﬂow after thrombolysis as
depicted by ST-segment resolution. This beneﬁt at the cost of
subjecting signiﬁcantly greater number of patients to signiﬁcant
myalgia, questions the usefulness of high dose statin in Indian
patients.
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Background: Beta blockers in ST-segment elevation myocardial
infarction (STEMI) are indicated in patients with high heart rates
(HR) or left ventricular (LV) dysfunction. But atrioventricular (AV)
blocks are the biggest concern in inferior MI with beta blockers. In
contrast ivabradine may lower heart rate with a lesser risk of AV
blocks.
Aim: To investigate the feasibility, tolerability, and the efﬁcacy of
ivabradine versusmetoprolol in acute inferior STEMI and during 30
days of follow up.
Methods: It was a prospective double blind single centre rando-
mized controlled study. Of 1032 patients with acute inferior STEMI,
564 patients did not fulﬁll the inclusion criteria and were excluded.
468 patientswere included in the study andwere randomized in 1:1
manner to ivabradine (groupA)andmetoprolol (groupB). 42patients
were lost on follow up and excluded. Per protocol analysis of 426
patients (groupA –210andgroupB –216)wasdone.Theprimaryend
point was 30-days incidence of MACE including death, reinfarction,
complete heart block (CHB), and heart failure. Secondary endpoints
included 30 days incidence of recurrent angina, readmission, ﬁrst or
second degree AV block, and tachyarrhythmias.
Results: Both the drugs decreased the mean heart rate to 62.22
 2.95 (groupA) vs 62.53 3.59 (group B) beats perminute (p = 0.33).
Ejection fraction improved in both the groups (2.4% in group A vs
3.2% in group B). The two groups did not differ signiﬁcantly in their
primary endpoints in terms of death (group A = 1.90% vs group
B = 1.85%, OR = 1.03, 95% CI = 0.25–4.17, p = 0.97), reinfarction (group
A = 0.95% vs group B = 0.93%, OR = 1.03, 95% CI = 0.14–7.37, p = 0.98),
heart failure (group A = 4.76% vs group B = 2.78%, OR = 1.75, 95%
CI = 0.62–4.90, p = 0.29), or CHB (0% vs 2.78%, OR = 0.08, 95%
CI = 0.004–1.37, p = 0.08). There were no signiﬁcant differences in
the secondary end points of recurrent angina, readmission, and
tachyarrhythmias but signiﬁcantly more ﬁrst degree AV blocks
occurred with metoprolol (13.89% vs 2.86%, OR = 5.48, 95%
CI = 2.23–13.47, p = 0.0002).
Conclusions: Ivabradine is well tolerated and equally effective as
metoprolol in acute inferior wall STEMI patients for lowering the
heart rate with signiﬁcant less risk of AV blocks.
Bifurcation stenting – A single center
experience
M. Dhanapal
Bifurcation is the division of an artery into 2 branches and it is a
common anatomical feature of the human coronary tree. Bifurca-
tion lesions are recognized as a common site for atherosclerotic
plaque build up and account for 15–20% of all interventions. These
lesions are complex and challenging for percutaneous intervention.
Numerousanatomicpatternsofbifurcationstenosisarepresentand
there is no consistent and reliable methodology to address these
complex lesions, that is, there is no ‘‘one size ﬁts all’’ solution to the
bifurcationpuzzle.Theoptimalpercutaneouscoronary intervention
technique remains undetermined.
Method:Weanalysed all the bifurcation lesion stenting procedures
done at our institution for three years from 2012 to 2015.
Results: Total of 138 cases of bifurcation stenting was done over a
period of three years. Therewere 96males and 42 females. Anterior
wall myocardial infarction accounted for 89% of all cases and the
remaining were inferior wall myocardial infarctions.
True bifurcation lesions were 53 in number.
86 cases had bifurcation lesion involving the LAD, 45 involved the
LCX, and 7 involved the RCA.
The predominant method of stenting was ‘‘T’’ at provision (TAP)
and involved 91 cases.
12casesunderwent ‘‘Minicrush’’, 8underwentsimultaneouskissing
stent (SKS) technique, and 27 cases underwent Classic T stenting.
Conclusion: The predominant technique of stenting was the TAP
technique,whichwas always followed by proximal optimization of
stent (POTS) to ensure side branch patency. Most of the bifurcation
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